A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

Conditions:   Essential Hypertension;   Primary Hypercholesterolemia Interventions:   Drug: Fimasartan;   Drug: Ezetimibe/Atorvastatin;   Drug: Fimasartan Placebo;   Drug: Ezetimibe/Atorvastatin Placebo Sponsor:   Boryung Pharmaceutical Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials